SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the June 2025 quarter is pegged at Rs. 8048.30 millions against Rs. 8110.00 millions recorded during the year-ago period.Modest increase of 12.69% in the Net Profit was reported from. 1816.50 millions to Rs. 2047.00  millions.The company reported a good operating profit of 2945.10 millions compared to 2652.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 8048.30 8110.00 -0.76 8048.30 8110.00 -0.76 37234.90 34072.50 9.28
Other Income 437.60 358.50 22.06 437.60 358.50 22.06 1425.60 1234.80 15.45
PBIDT 2945.10 2652.70 11.02 2945.10 2652.70 11.02 13118.50 10241.30 28.09
Interest 4.20 3.70 13.51 4.20 3.70 13.51 13.10 18.00 -27.22
PBDT 2940.90 2649.00 11.02 2940.90 2649.00 11.02 13152.30 8787.20 49.68
Depreciation 155.20 164.10 -5.42 155.20 164.10 -5.42 667.90 696.80 -4.15
PBT 2785.70 2484.90 12.11 2785.70 2484.90 12.11 12484.40 8090.40 54.31
TAX 738.70 668.40 10.52 738.70 668.40 10.52 3293.80 2243.50 46.82
Deferred Tax 0.20 35.10 -99.43 0.20 35.10 -99.43 62.00 -113.60 -154.58
PAT 2047.00 1816.50 12.69 2047.00 1816.50 12.69 9190.60 5846.90 57.19
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 36.59 32.71 11.87 36.59 32.71 11.87 35.23 30.06 17.21

Glaxosmithkline Phar Share Price

2393.25 32.95 (1.40%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×